Skip to main content

Advertisement

Log in

p.P2063S: a neutral VWF variant masquerading as a mutation

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kasatkar P, Ghosh K, Shetty S (2013) A common founder mutation p.P2063S in exon 36 of VWF in 11 unrelated Indian von Willebrand disease (VWD) families. Ann Hematol. doi:10.1007/s00277-013-1680-x

    Google Scholar 

  2. Eikenboom J, Hilbert L, Ribba AS, Hommais A, Habart D, Messenger S, Al-Buhairan A, Guilliatt A, Lester W, Mazurier C, Meyer D, Fressinaud E, Budde U, Will K, Schneppenheim R, Obser T, Marggraf O, Eckert E, Castaman G, Rodeghiero F, Federici AB, Batlle J, Goudemand J, Ingerslev J, Lethagen S, Hill F, Peake I, Goodeve A (2009) Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study. J Thromb Haemost 7:1304–1312

    Article  CAS  PubMed  Google Scholar 

  3. Johansson AM, Halldén C, Säll T, Lethagen S (2011) Variation in the VWF gene in Swedish patients with type 1 von Willebrand disease. Ann Hum Genet 75:447–455

    Article  CAS  PubMed  Google Scholar 

  4. Wang QY, Song J, Gibbs RA, Boerwinkle E, Dong JF, Yu FL (2013) Characterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 Genomes. J Thromb Haemost 11:261–269

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Baronciani L, Cozzi G, Canciani MT, Peyvandi F, Srivastava A, Federici AB, Mannucci PM (2003) Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients. Blood Cells Mol Dis 30:264–270

    Article  CAS  PubMed  Google Scholar 

  6. Gupta PK, Saxena R, Adamtziki E, Budde U, Oyen F, Obser T, Schneppenheim R (2008) Genetic defects in von Willebrand disease type 3 in Indian and Greek patients. Blood Cells Mol Dis 41:219–222

    Article  CAS  PubMed  Google Scholar 

  7. Ahmad F, Budde U, Jan R, Oyen F, Kannan M, Saxena R, Schneppenheim R (2013) Phenotypic and molecular characterisation of type 3 von Willebrand disease in a cohort of Indian patients. Thromb Haemost 109:652–660

    Article  CAS  PubMed  Google Scholar 

  8. Hampshire DJ, Abuzenadah AM, Cartwright A, Al-Shammari NS, Coyle RE, Eckert M, Al-Buhairan AM, Messenger SL, Budde U, Gürsel T, Ingerslev J, Peake IR, Goodeve AC (2013) Identification and characterisation of mutations associated with von Willebrand disease in a Turkish patient cohort. Thromb Haemost. doi:10.1160/TH13-02-0135

  9. Hampshire DJ, Goodeve AC (2011) The molecular basis of von Willebrand disease: the under investigated, the unexpected and the overlooked. Haematologica 96:798–800

    Article  CAS  PubMed  Google Scholar 

  10. Schneppenheim R, Budde U, Beutel K, Hassenpflug W-A, Hauch H, Obser T, Oyen F, Schneppenheim S, Schrum J (2009) Response to DDAVP in children with von Willebrand disease type 2. Hämostaseologie 29:143–148

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are supported by the National Institutes of Health program project grant HL081588 Zimmerman Program for the Molecular and Clinical Biology of VWD.

Conflict of interest

The authors state that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel J. Hampshire.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hampshire, D.J., Goodeve, A.C. p.P2063S: a neutral VWF variant masquerading as a mutation. Ann Hematol 93, 505–506 (2014). https://doi.org/10.1007/s00277-013-1817-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-013-1817-y

Keywords

Navigation